FRISON, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 199
EU - Europa 159
AS - Asia 141
SA - Sud America 21
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 527
Nazione #
US - Stati Uniti d'America 198
CN - Cina 66
GB - Regno Unito 59
SG - Singapore 44
BR - Brasile 19
SE - Svezia 17
IT - Italia 16
HK - Hong Kong 15
IE - Irlanda 14
FI - Finlandia 12
DE - Germania 11
FR - Francia 11
RU - Federazione Russa 9
IN - India 4
PL - Polonia 4
IQ - Iraq 3
VN - Vietnam 3
BD - Bangladesh 2
BE - Belgio 2
KR - Corea 2
AR - Argentina 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CA - Canada 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
JP - Giappone 1
NG - Nigeria 1
NL - Olanda 1
PE - Perù 1
TG - Togo 1
TN - Tunisia 1
UA - Ucraina 1
Totale 527
Città #
Southend 52
Dallas 40
Chandler 32
Woodbridge 30
Beijing 19
Singapore 18
Hong Kong 15
Ashburn 14
Dublin 14
Ann Arbor 12
Jinan 9
Shenyang 7
São Paulo 5
Verona 5
Guangzhou 4
Hebei 4
Jacksonville 4
Lawrence 4
Princeton 4
Wilmington 4
Changsha 3
London 3
Los Angeles 3
Munich 3
Polska 3
San Francisco 3
Turku 3
Vicenza 3
Brussels 2
Chennai 2
Columbus 2
Düsseldorf 2
Frankfurt am Main 2
Helsinki 2
Jaú 2
Nanjing 2
The Dalles 2
Washington 2
Xi'an 2
Addis Ababa 1
Baku 1
Boardman 1
Bologna 1
Bragança Paulista 1
Brasília 1
Buenos Aires 1
Canberra 1
Canoas 1
Chester 1
Clarksburg 1
Criciúma 1
Dhaka 1
Dobczyce 1
Duhok 1
Erbil 1
Fayetteville 1
Fremont 1
Fuzhou 1
Goiânia 1
Haikou 1
Hefei 1
Ho Chi Minh City 1
Houston 1
Jaboatão dos Guararapes 1
Jequié 1
Jiaxing 1
Jinhua 1
Lima 1
Lomé 1
Mahdia 1
Montreal 1
Mrkonjić Grad 1
Nanchang 1
New Delhi 1
Nobres 1
Oklahoma City 1
Pittsburgh 1
Providence 1
Recife 1
Richmond 1
Rio de Janeiro 1
Rolante 1
Salsomaggiore Terme 1
Santa Clara 1
Seoul 1
Sulaymaniyah 1
Thornton Heath 1
Thái Bình 1
Tokyo 1
Vienna 1
Volta Redonda 1
Vĩnh Long 1
Totale 395
Nome #
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 136
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. 113
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response 109
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. 105
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements 73
Totale 536
Categoria #
all - tutte 2.089
article - articoli 835
book - libri 0
conference - conferenze 1.254
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 1 4 5 2 0 0 0 0 3 2
2021/202231 5 9 0 3 3 0 0 2 0 0 1 8
2022/202384 4 11 6 15 7 22 2 4 11 1 1 0
2023/202444 0 5 3 2 5 8 0 1 1 4 11 4
2024/2025117 6 2 5 18 5 6 7 6 17 5 15 25
2025/202671 26 43 2 0 0 0 0 0 0 0 0 0
Totale 536